JP2025508098A5 - - Google Patents

Info

Publication number
JP2025508098A5
JP2025508098A5 JP2024553621A JP2024553621A JP2025508098A5 JP 2025508098 A5 JP2025508098 A5 JP 2025508098A5 JP 2024553621 A JP2024553621 A JP 2024553621A JP 2024553621 A JP2024553621 A JP 2024553621A JP 2025508098 A5 JP2025508098 A5 JP 2025508098A5
Authority
JP
Japan
Prior art keywords
nintedanib
use according
tuberculosis
drugs
ethanesulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024553621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508098A (ja
JP7844766B2 (ja
Filing date
Publication date
Priority claimed from CN202210463752.6A external-priority patent/CN114732818B/zh
Application filed filed Critical
Publication of JP2025508098A publication Critical patent/JP2025508098A/ja
Publication of JP2025508098A5 publication Critical patent/JP2025508098A5/ja
Application granted granted Critical
Publication of JP7844766B2 publication Critical patent/JP7844766B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024553621A 2022-04-29 2023-03-16 抗特発性肺線維症薬ニンテダニブの結核を治療するための使用 Active JP7844766B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210463752.6 2022-04-29
CN202210463752.6A CN114732818B (zh) 2022-04-29 2022-04-29 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用
PCT/CN2023/081772 WO2023207398A1 (zh) 2022-04-29 2023-03-16 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用

Publications (3)

Publication Number Publication Date
JP2025508098A JP2025508098A (ja) 2025-03-21
JP2025508098A5 true JP2025508098A5 (https=) 2025-06-16
JP7844766B2 JP7844766B2 (ja) 2026-04-14

Family

ID=82285173

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024553621A Active JP7844766B2 (ja) 2022-04-29 2023-03-16 抗特発性肺線維症薬ニンテダニブの結核を治療するための使用

Country Status (5)

Country Link
US (1) US20250099458A1 (https=)
JP (1) JP7844766B2 (https=)
CN (1) CN114732818B (https=)
WO (1) WO2023207398A1 (https=)
ZA (1) ZA202405173B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114732818B (zh) * 2022-04-29 2023-02-10 首都医科大学附属北京胸科医院 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用
CN115645405B (zh) * 2022-11-10 2023-11-21 南方医科大学 顺苯磺酸阿曲库铵在制备抗结核抗生素增效剂中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857725A (zh) * 2006-04-11 2006-11-08 济南帅华医药科技有限公司 一种含增效剂的复方抗结核药物缓释制剂
EP2311457A1 (en) * 2009-10-19 2011-04-20 Forschungszentrum Borstel Pharmaceutical compositions for treating infections with drug resistant mycobacteria
WO2015107482A1 (en) * 2014-01-17 2015-07-23 Piramal Enterprises Limited Pharmaceutical combination for treatment of tuberculosis
DK3377064T3 (da) * 2016-01-08 2019-09-23 Nerre Therapeutics Ltd Orvepitant til behandling af kronisk hoste
CN107019697A (zh) * 2016-02-02 2017-08-08 瑞阳(苏州)生物科技有限公司 预防或治疗纤维化疾病的药物组合物及其应用
GB201607865D0 (en) * 2016-05-05 2016-06-22 Ucl Business Plc Anti-tuberculous polymersomes
CN105902507A (zh) * 2016-06-12 2016-08-31 佛山市腾瑞医药科技有限公司 一种乙磺酸尼达尼布制剂及其应用
CN114732818B (zh) * 2022-04-29 2023-02-10 首都医科大学附属北京胸科医院 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用

Similar Documents

Publication Publication Date Title
JP2022537551A5 (https=)
JP2025508098A5 (https=)
JP2024074963A5 (https=)
JP2018507243A5 (https=)
JP2019517542A5 (https=)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
TWI822652B (zh) 治療及預防hiv與aids之方法
CN104812394B (zh) 吩噻嗪衍生物及其治疗肺结核的用途
JP2021509395A5 (https=)
JP2019218379A5 (https=)
JP2022508513A5 (https=)
JP2024502446A5 (https=)
RU2007101686A (ru) Комбинированная композиция
JP2012505830A5 (https=)
JP2022550828A5 (https=)
CN101309675A (zh) 口服剂量组合的药品包装
Elliott Timing treatment to the rhythm of disease: A short course in chronotherapeutics
JP2024520690A5 (https=)
JPH0140009B2 (https=)
JP2022019937A (ja) ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物
TW200401636A (en) Drug composition for blood sugar control
JP2022526495A5 (https=)
JP2024531799A5 (https=)
JP6197515B2 (ja) 医薬組成物
JP2025527471A5 (https=)